VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 336 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2018. The put-call ratio across all filers is 2.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $581,000 | -12.6% | 25,000 | -40.1% | 0.28% | +80.3% |
| Q1 2018 | $665,000 | -4.5% | 41,750 | +24.6% | 0.16% | -0.6% |
| Q4 2017 | $696,000 | -59.8% | 33,500 | -66.5% | 0.16% | -70.5% |
| Q2 2017 | $1,730,000 | +526.8% | 100,000 | +300.0% | 0.54% | +654.9% |
| Q1 2017 | $276,000 | -95.5% | 25,000 | -94.1% | 0.07% | -97.5% |
| Q4 2016 | $6,171,000 | +1431.3% | 425,000 | +2025.0% | 2.88% | +1467.4% |
| Q2 2016 | $403,000 | -52.1% | 20,000 | -37.5% | 0.18% | -4.2% |
| Q1 2016 | $842,000 | -83.4% | 32,000 | -36.0% | 0.19% | -88.2% |
| Q4 2015 | $5,083,000 | +2035.7% | 50,000 | +4559.8% | 1.63% | +3975.0% |
| Q2 2015 | $238,000 | – | 1,073 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |